Enliven Therapeutics, Inc. (ELVN): SC 13D/A filed Feb 16, 2024

Form type

SC 13D/A

Filing date

Feb 16, 2024

Accession number

0001104659-24-024915

Filer

Enliven Therapeutics, Inc. (CIK 1672619)